WYNNEFIELD PARTNERS SMALL CAP VALUE LP
WYNNEFIELD PARTNERS SMALL CAP VALUE LP's purchase track record
How the stock did after each of WYNNEFIELD PARTNERS SMALL CAP VALUE LP's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/28/2023 | DLHC | $81K | -25.7% | -12.2% | +13.3% |
| 9/9/2022 | NATR | $46K | -13.3% | -9.7% | -5.1% |
| 9/1/2022 | NATR | $121K | -13.9% | +6.3% | +0.4% |
| 8/23/2022 | NATR | $548K | -10.8% | -1.1% | -3.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Transaction History
| DLHC | ▼ Sell | Open Market | 210,000 | $2.4M | 3/14/2023 | View on chart |
| DLHC | ▼ Sell | Open Market | 40,000 | $450K | 3/14/2023 | View on chart |
| DLHC | ▲ Buy | Open Market | 4,489 | $55K | 2/28/2023 | View on chart |
| DLHC | ▲ Buy | Open Market | 2,053 | $25K | 2/28/2023 | View on chart |
| NATR | ▲ Buy | Open Market | 1,569 | $14K | 9/15/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 3,431 | $31K | 9/15/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 172 | $2K | 9/9/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 1,332 | $12K | 9/8/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 2,914 | $27K | 9/8/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 1,824 | $17K | 9/2/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 3,990 | $38K | 9/2/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 1,911 | $18K | 9/1/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 874 | $8K | 9/1/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 1,982 | $19K | 8/30/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 4,333 | $41K | 8/30/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 1,428 | $14K | 8/29/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 3,124 | $31K | 8/29/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 2,393 | $24K | 8/26/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 5,234 | $52K | 8/26/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 9,622 | $93K | 8/25/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 21,041 | $203K | 8/25/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 1,096 | $11K | 8/24/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 2,395 | $24K | 8/24/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 2,524 | $25K | 8/23/2022 | View on chart |
| NATR | ▲ Buy | Open Market | 1,154 | $12K | 8/23/2022 | View on chart |
| DLHC | ▼ Sell | Other | 17,694 | $66K | 10/27/2021 | View on chart |
| DLHC | ▼ Sell | Other | 35,925 | $134K | 10/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
DLH Secures $19.1M NIH Cybersecurity Task Order
DLH Holdings Corp. was awarded a new task order from the National Institutes of Health to provide cybersecurity operations support services. The contract is valued at up to $19.1 million and focuses on risk management framework support for the NIH Center for Information Technology. This new business win adds to the company's revenue pipeline while the stock remains near its 52-week low.
DLH Secures $19.1M NIH Cybersecurity Task Order. DLH Holdings Corp. was awarded a new task order from the National Institutes of Health to provide cybersecurity operations support services. The contract is valued at up to $19.1 million and focuses on risk management framework support for the NIH Center for Information Technology. This new business win adds to the company's revenue pipeline while the stock remains near its 52-week low.